- Home
- SIGA vs NBB Comparison
SIGA vs NBB Comparison
Compare SIGA & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- NBB
- Stock Information
- Founded
- SIGA 1995
- NBB 2009
- Country
- SIGA United States
- NBB United States
- Employees
- SIGA N/A
- NBB N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- NBB Finance Companies
- Sector
- SIGA Health Care
- NBB Finance
- Exchange
- SIGA Nasdaq
- NBB Nasdaq
- Market Cap
- SIGA 443.4M
- NBB 478.3M
- IPO Year
- SIGA 1997
- NBB N/A
- Fundamental
- Price
- SIGA $6.32
- NBB $15.53
- Analyst Decision
- SIGA
- NBB
- Analyst Count
- SIGA 0
- NBB 0
- Target Price
- SIGA N/A
- NBB N/A
- AVG Volume (30 Days)
- SIGA 422.2K
- NBB 73.9K
- Earning Date
- SIGA 03-11-2025
- NBB 01-01-0001
- Dividend Yield
- SIGA 9.53%
- NBB 8.64%
- EPS Growth
- SIGA N/A
- NBB N/A
- EPS
- SIGA 1.20
- NBB N/A
- Revenue
- SIGA $173,731,386.00
- NBB N/A
- Revenue This Year
- SIGA $16.79
- NBB N/A
- Revenue Next Year
- SIGA $15.08
- NBB N/A
- P/E Ratio
- SIGA $5.30
- NBB N/A
- Revenue Growth
- SIGA 399.31
- NBB N/A
- 52 Week Low
- SIGA $4.26
- NBB $13.67
- 52 Week High
- SIGA $12.83
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- SIGA 51.04
- NBB 52.65
- Support Level
- SIGA $6.16
- NBB $15.24
- Resistance Level
- SIGA $6.58
- NBB $15.38
- Average True Range (ATR)
- SIGA 0.26
- NBB 0.17
- MACD
- SIGA 0.04
- NBB 0.07
- Stochastic Oscillator
- SIGA 68.67
- NBB 94.47
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests primarily in a diversified portfolio of taxable municipal securities.